Katherine Uyhazi, MD, Ophthalmology, Philadelphia, PA, Hospital of the University of Pennsylvania

KatherineE.UyhaziMDPhD

OphthalmologyPhiladelphia, PA

Retinal Disease

Instructor of Ophthalmology, Retinal Degeneration, Perelman School of Medicine

Dr. Uyhazi is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Uyhazi's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Scheie Eye Institute, Perelman Center for Advanced Medicine
    Philadelphia, PA 19104
    Phone(215) 662-8676
    Fax(215) 243-4696
  • Is this information wrong?

Summary

  • Dr. Katherine Uyhazi is an ophthalmologist in Philadelphia, PA who specializes in inherited retinal diseases. She received her medical degree from Yale University School of Medicine and has a PhD in cell biology. Her research laboratory is developing new gene therapy and stem cell-based therapies for blinding diseases.
  • Scheie Welcomes Dr. Katherine Uyhazi

Skills & Expertise

  • Gene therapy, Retinitis pigmentosa, Leber congenital amaurosis, Laboratory research, Retinal degeneration, Electroretinography, Visual field testing, Ocular Genetics, Stem Cell Research, genetic testing

Education & Training

  • University of Pennsylvania
    University of PennsylvaniaFellowship
  • Scheie Eye Institute - University of PennsylvaniaResidency
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkInternship
  • Yale University School of Medicine
    Yale University School of MedicineMedicalSchool
  • The College of New JerseyOtherTraining

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2017 - 2020
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • NOACs May Carry Lower Risk of Intraocular Hemorrhage Than WarfarinJanuary 02, 2018

Hospital Affiliations